D. Nitsche

Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trial

Hans‐Joachim Schmoll, Burghardt Wittig, Dirk Arnold et al. · Journal of Cancer Research and Clinical Oncology · 2014 · 97 citations · Full text

Medicine, Oncology, Pharmacology +16

Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib

Osman Öcal, Regina Schinner, Kerstin Schütte et al. · Cancer Imaging · 2022 · 20 citations · Full text

Medicine, Oncology, Radiology +17

Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon-α-2c in patients with advanced colorectal cancer: final results of a randomised phase III study

H. Hausmaninger, Renate Moser, H. Samonigg et al. · European Journal of Cancer · 1999 · 16 citations

Medicine, Oncology, Pharmacology +13